Pilot Study Evaluating Efficacy and Economic Advantage of Sucrosomial Iron Post-operative Supplementation vs Standard of Care in Patients After Cardiac Surgery

Principal Investigator: Margit Kaufman, MD
Coordinator: Hanna Kim
Phone: 201-894-9713
NCT #: 06970925
Englewood Health IRB #: E-25-119
More Information (clinicaltrials.gov)
 

ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects InDicatEd for TAVR

Principal Investigator: Joseph De Gregorio, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 03735667
Englewood Health IRB #: E-21-860
More Information (clinicaltrials.gov)

Champion AF: WATCHMAN FLX versus NOAC for Embolic Protection in the Management of Patients with Non-Valvular Atrial Fibrillation

Principal Investigator: Grant Simons, MD
Coordinator: Dara Herman
Phone: 201-894-3944
NCT #: 04394546
Englewood Health IRB #: E-20-839
More Information (clinicaltrials.gov)

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women (ROMA:Women)

Principal Investigator: Molly Schultheis, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 04124120
Englewood Health IRB #: E-23-928
More Information (clinicaltrials.gov)

Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients who have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement

Principal Investigator: Ramin Hastings, MD
Coordinator: Taylor Dublin
Phone: 201-894-5804
NCT #: 05932615
Englewood Health IRB #: E-25-152
More Information (clinicaltrials.gov)

Medtronic Global SYMPLICITY Registery (GSR) Denervation Findings in Real World (DEFINE) – US Cohort

Principal Investigator: Joseph De Gregorio, MD
Coordinator: Taylor Dublin
Phone: 201-894-5804
NCT #: 01534299
Englewood Health IRB #: E-25-158
More Information (clinicaltrials.gov)

REvascularization CHoices Among under-Represented Groups Evaluation: The RECHARGE Trial

Principal Investigator: Molly Schultheis, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 06399705
Englewood Health IRB #: E-24-970
More Information (clinicaltrials.gov)

REvascularization CHoices Among under-Represented Groups Evaluation: The RECHARGE Trial, Women

Principal Investigator: Molly Schultheis, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 06399692
Englewood Health IRB #: E-24-970
More Information (clinicaltrials.gov)

SELUTION4DeNovo Small Vessel: A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR014 PTCA Drug Eluting Balloon in the Treatment of Subjects with De Novo Coronary Lesions in Small Vessels

Principal Investigator: Joseph De Gregorio, MD
Coordinator: Taylor Dublin
Phone: 201-894-5804
NCT #: 05946629
Englewood Health IRB #: E-24-994
More Information (clinicaltrials.gov)

The One-Month Dual Anti-Platelet Therapy with Ticagrelor In CABG Patients Trial (ODIN Trial)

Principal Investigator: Molly Schultheis, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 05997693
Englewood Health IRB #: E-24-985
More Information (clinicaltrials.gov)
 

Gestational Diabetes and Metabolic Risk Reduction in a Community-based Wellness Program

Principal Investigator: Anita Ramsetty, MD
Coordinator: Taylor Dublin
Phone: 201-894-5804
NCT #: Pending
Englewood Health IRB #: E-25-116
 

Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent or Refractory Clostridium Difficile Infection (CDI)

Principal Investigator: Marc Fiorillo, MD
Coordinator: Dara Herman
Phone: 201-894-3944
NCT #: 01942447
Englewood Health IRB #: E-13-507
More Information (clinicaltrials.gov)
 

A021806: A Phase III Trial of Periperative vs. Adjuvant chemotherapy for Resectable Pancreatic Cancer

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04340141
Englewood Health IRB #: E-21-848
More Information (clinicaltrials.gov)

A Randomized, Open-label, Phase 3 Study of MK-2780 vs Chemotherapy (Docetaxel or Pemetrezed) in Previously Treated Advanced or Metastatic Nonsquamous Non small Cell Lung Cancer (NSCLC) with EGFR mutations or Other Genomic Alterations

Principal Investigator: Lewis Attas, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 06074588
Englewood Health IRB #: E-25-109
More Information (clinicaltrials.gov)

Additional Support Program via Text Messaging and Telephone-based Counseling for Breast Cancer receiving Hormonal Therapy

Principal Investigator: Allison Imahiyerobo, APN
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04379570
Englewood Health IRB #: E-25-113
More Information (clinicaltrials.gov)

An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects with Solid Tumors or Lymphoma

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 03556228
Englewood Health IRB #: E-24-977
More Information (clinicaltrials.gov)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial

Principal Investigator: Allison Imahiyerobo, APN
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 5896189
Englewood Health IRB #: E-25-136
More Information (clinicaltrials.gov)

Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics

Principal Investigator: Allison Imahiyerobo, APN
Coordinator: Hanna Kim
Phone: 201-894-9713
NCT #: 06418204
Englewood Health IRB #: E-25-135
More Information (clinicaltrials.gov)

NRG-BN003: A Phase III Trial of Observation vs. Irradiation for a Gross Totally Resected Grade II Meningioma

Principal Investigator: Malay Rao, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03180268
Englewood Health IRB #: E-26-170
More Information (clinicaltrials.gov)

NRG-BN011: A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients With Mehtylated MGMT Promoter Glioblastoma

Principal Investigator: Maxwell Janosky, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 05095376
Englewood Health IRB #: E-24-998
More Information (clinicaltrials.gov)

NRG-GU009: Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Predict-RT)

Principal Investigator: Malay Rao, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04513717
Englewood Health IRB #: E-25-142
More Information (clinicaltrials.gov)

NRG-GU010: Parallel Phase III Randomized Trials of Genomic Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)

Principal Investigator: Malay Rao, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 05050084
Englewood Health IRB #: E-25-143
More Information (clinicaltrials.gov)

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnofe Irreversible Electroporation (IRE) System

Principal Investigator: Cherif Boutros, MD
Coordinator: Taylor Dublin
Phone: 201-894-5840
NCT #: 06937996
Englewood Health IRB #: E-24-987
More Information (clinicaltrials.gov)

Perioperative versus Adjuvant Systemic Therapy in Patients with Resectable Non-Small Cell Lung Cancer – PROSPECT LUNG

Principal Investigator: Lewis Attas, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 06632327
Englewood Health IRB #: E-25-134
More Information (clinicaltrials.gov)

Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Principal Investigator: Cherif Boutros, MD
Coordinator: Taylor Dublin
Phone: 201-894-5840
NCT #: 06681818
Englewood Health IRB #: E-24-982
More Information (clinicaltrials.gov)

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 05929768
Englewood Health IRB #: E-24-101
More Information (clinicaltrials.gov)

Testing the addition of bevacizumab to Osimertinib (AZD9291) as a first-treatment for patients with EGFR-mutant lung cancer that has metastasized

Principal Investigator: Lewis Attas, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04181060
Englewood Health IRB #: E-24-968
More Information (clinicaltrials.gov)

Testing the use of Combination Therapy in Adult Patients with Newly Diagnosed Multiple Myeloma

Principal Investigator: Maxwell Janosky, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04566328
Englewood Health IRB #: E-25-139
More Information (clinicaltrials.gov)
 

A phase II study of dose-dense gemcitabine plus cisplatin (ddGC) in patients with muscle-invasive bladder cancer with bladder preservation for those patients whose tumors harbor deleterios DNA damage response (DDR) gene alterations

Principal Investigator: Brian Kim, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03609216
Englewood Health IRB #: E-18-748
More Information (clinicaltrials.gov)
 

A011801: The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04457596
Englewood Health IRB #: E-21-850
More Information (clinicaltrials.gov)

A012303, ShortStop-HER2: Shortened duration of adjuvant therapy in patients with early-stage HER2+ breast cancer who achieve pCR after neoadjuvant chemotherapy with HER2 blockade

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 0876714
Englewood Health IRB #: E-25-165
More Information (clinicaltrials.gov)

DCIS: RECAST Trial - Dcutal Carcinomain Situ: Re-evaluating Conditions for Active Surveillance Suitability as Treatment: a breast cancer prevention pilot study

Principal Investigator: Jennifer Marti, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 06075953
Englewood Health IRB #: E-25-126
More Information (clinicaltrials.gov)
 

A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04094688
Englewood Health IRB #: E-19-792
More Information (clinicaltrials.gov)
 

IMIGASTRIC II: Prospective, observational, multicenter study on minimally invasive gastrectomy for gastric cancer: robotic, laparoscopic and open surgery compared on operative and follow-up outcomes

Principal Investigator: Steven Brower, MD
Coordinator: William Dippolito
Phone: 201-608-2572
NCT #: 02751086
Englewood Health IRB #: E-16-673
More Information (clinicaltrials.gov)
 

Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Iliofemoral Venous Obstruction

Principal Investigator: Steven Elias, MD
Coordinator: Hanna Kim
Phone: 201-894-9713
NCT #: 05489588
Englewood Health IRB #: E-22-912
More Information (clinicaltrials.gov)

TANGO-3: Temsirolimus Adventitial Delivery to Improve Angioplasty and/or Atherectomy Revascularization Outcomes Below the Knee (Phase 3)

Principal Investigator: Thomas Bernik, MD
Coordinator: Taylor Dublin
Phone: 201-894-5840
NCT #: 04433572
Englewood Health IRB #: E-24-107
More Information (clinicaltrials.gov)